Skip to main content
SpringerLink
Log in

Cefpodoxime — utility in respiratory tract infections and typhoid fever

  • Special Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Cefpodoxime is a oral third generation cephalosporin active against most of gram positive and gram negative bacteria except Pseudomonas, B. fragilis and Entrococcous. Clinical studies have confirmed efficacy of cefpodoxime in acute otitis media, sinusitis and tosillopharyngitis. Twice daily administration and safety profile increases compliance and decreases failure rate. It has a role as switch over therapy from intravenous ceftriaxone in serious respiratory tract infections (RTIs). In areas where common respiratory pathogens show decreased sensitivity to penicillins and macrolides cefpodoxime can be used as empirical first line therapy in respiratory tract infections. It seems to be a promising molecule in pediatric typhoid fever because of its excellent activity against Salmonella species but clinical trials are limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wise K. β lactams. Cephalosporins. In O’Gradej F, Lambert H, Finch RG, Greenwood D, eds.Antibiotic and Chemotherapy. New York, Churchill Livingstone, 1997; 202–255.

    Google Scholar 

  2. Pichichero ME. Evaluating the need, timing, and best choice of antibiotic therapy for acute otitis media and tonsillopharyngitis infections in children.Pediatr inf Dis J 2000; 19: S131–140.

    Article  CAS  Google Scholar 

  3. Frampton JE, Brogden RN. Cefpodoxime Proxetil. A review of its antibacterial avtivity pharmacokinetic properties and therapeutic potential.Drugs 1992; 44: 889–917.

    PubMed  CAS  Google Scholar 

  4. Schatz BS, Karavokiros KT, Taeubel MA, Itokazu GS. Comparison of cefprozil, cefpodoxime proxetil, loracef, cefixime and ceftibuten.Ann Pharmacother 1996; 30: 258–268.

    PubMed  CAS  Google Scholar 

  5. Kumazawa J. Summary of clinical experience with cefpodoxime proxetil in adults in Japan.Drugs 1991; 42: 1–66.

    Article  PubMed  Google Scholar 

  6. Kearns GL, Abdel-Rahman SM, Jacobs RF, Wells JG, Borin MT. Cefpodoxime pharmacokinetics in children, effect of food.Pediatr Inf Dis J 1998, 17: 799–804.

    Article  CAS  Google Scholar 

  7. Rusell W, Steele MD, Thomas MP, Beque RE. Compliance issues related to selection of antibiotic suspensions for children.Pediatr Inf Dis J 2001; 20: 1–5

    Article  Google Scholar 

  8. Bairamis TN, Nikolopoulos TP, Kafetzis DA, Begue P, Lenfant B, Kandiloros DC, Apostolopoulos NJ. Concentration of cefpodoxime in plasma, adenoid and tonsillar tissue after repeated administration of cefpodoxime proxetil in children.J Antimicro Chemothera 1996; 37: 821–824.

    Article  CAS  Google Scholar 

  9. Liu P, Muller M, Grant M, Webb AI, Obermann B, Dezendorf H. Interstilial tissue concentration of cefpodoxime.J Antimicrob Chemother 2002; 50: 19–22.

    Article  PubMed  CAS  Google Scholar 

  10. Pichichero ME, Margolis PA. Comparison of cephalosporins and penicillins in treatment of group A beta-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial copathogenicity.Pediatr Inf Dis J 1991; 10: 275–281.

    Article  CAS  Google Scholar 

  11. Portier H, Chavanet P, Waldner-Combernoux Aet al. Five versus 10 day treatment of streptococcal pharyngitonsillitisia randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl pecicillin.Scand J Infect Dis 1994; 26: 59–66.

    PubMed  CAS  Google Scholar 

  12. Pichichiero ME, Gooch WM, Rodriguez Wet al. Effective shot course treatment of acute group A beta-haemolytic streptococcalpharyngitis. Ten days of penicillin vs 5 day or 10 day cefpodoxime therapy in children.Arch Pediatr Adolesc Med 1994; 148: 1053–1060.

    Google Scholar 

  13. Block SL. Short course antimicrobial therapy of streptococcal pharyngtis.Clin Pediatr 2003; 42: 663–671.

    Article  Google Scholar 

  14. Cohen R. Clinical efficacy of cefpodoxime in respiratory tract infection.J Antimicrob Chemother 2002; 50: 23–27.

    PubMed  CAS  Google Scholar 

  15. van Dyk JC, Terespolsky SA, Meyer CS, Van Niekerk CH, Klugman KP. Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media.Pediatr Infect Dis J 1997; 16: 79–81.

    Article  PubMed  Google Scholar 

  16. Klein M. Multicenter trial of cefpodoxime vs amoxicillinclavulanate in acute lower respiratory tract infections in chilhood.Pediatr Inf Dis J 1995; 14: S 19–22.

    Article  Google Scholar 

  17. V Goelet al. Cefpodoxime: efficacy and safety in the treatment of respiratory tract infections.JAPI 1996; 44: 965–966.

    Google Scholar 

  18. Hendrickson JR, North DS. Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil.Ann Pharmacother 1995; 29: 561–565.

    PubMed  CAS  Google Scholar 

  19. Jones RN, Zurenko GE. Prediction of bacterial susceptibility of cefpodoxime by using ceftraixone minimum inhibitory concentration result.Diagn Microbiol Infect Dis 1993; 17: 313–316.

    Article  PubMed  CAS  Google Scholar 

  20. Jankert R, Meer WM. Sequential therapy with intravenous and oral cephalosporins.J Antimicro Chemo 1994; 33: 169–177.

    Article  Google Scholar 

  21. Parry CM. Typhoid fever.Curr Infect Dis Rep 2004; 6: 27–33.

    Article  PubMed  Google Scholar 

  22. Dhanjee A, Sheikh MA, Yabub M, Alam SE. Orelox (cefpodoxime) in typhoid fever.J Pak Med Assoc 1999; 49: 148–149.

    PubMed  CAS  Google Scholar 

  23. Dyke JW, Angones D, Bhakta D, Tenjaria G, Kumar A. Antimicrobial activity of new antibiotics against bacterial isolates from a community hospital.Chemotherapy 1993; 39: 315–321.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University College of Medical Sciences and Guru Tegh Bahadur Hospital, Delhi, India

    Anju Aggarwal & Suman Rath

Authors
  1. Anju Aggarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suman Rath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anju Aggarwal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aggarwal, A., Rath, S. Cefpodoxime — utility in respiratory tract infections and typhoid fever. Indian J Pediatr 71, 413–415 (2004). https://doi.org/10.1007/BF02725629

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02725629

Key words

Search

Navigation